Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD)

NCT04769258 · clinicaltrials.gov ↗

UNKNOWN

Status

1380

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Diseases

Interventions

BIOLOGICAL: Pfizer Comirnaty vaccine

Sponsor

Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)